Sign In
Buy HEPA
$0.0600
-0.0030 (-4.76%)
At Close: Jun 03, 2026
Poxel : premiers résultats positifs dans la NASH | Zone bourse
09:28am, Wednesday, 24'th Jun 2020
Pour recevoir l'information de POXEL en temps réel, faites-en la demande à [email protected]
Critical Contrast: GENFIT S A/ADR (GNFT) and Its Peers
01:36am, Wednesday, 24'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare GENFIT S A/AD
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, in
ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents | | IT Business Net
03:11pm, Tuesday, 23'rd Jun 2020
Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform Capabilities ANN ARBOR, MI / ACCESSWIRE / June 23, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a
Fate of Intercept's NASH drug clouded by murky FDA review delays
01:49pm, Tuesday, 23'rd Jun 2020
The agency had planned to announce its decision on whether or not to approve the first treatment for the fatty liver disease known as NASH this week.
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Hepion Pharmaceuticals' CRV431 Demonstrates Efficacy in Kidney Fibrosis | | IT Business Net
09:11pm, Monday, 22'nd Jun 2020
Results Support CRV431's Potential to More Broadly Treat Fibrotic Diseases EDISON, NJ / ACCESSWIRE / June 22, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) ("Hepion" or the "Co
Hepion Pharmaceuticals' CRV431 Demonstrates Efficacy in Kidney Fibrosis
08:15pm, Monday, 22'nd Jun 2020
A third group of eight mice, the Sham group, did not undergo surgery and did not receive drug treatment. The fibrotic scarring in response to the UUO procedure was visualized by Sirius red staining o
First National Study Predicts an Escalating Epidemic of Nonalcoholic Fatty Liver Disease (NAFLD)
12:00pm, Monday, 22'nd Jun 2020
TORONTO — The first-ever Canadian study to forecast the growing burden of nonalcoholic fatty liver disease (NAFLD or “fatty liver disease”) and its more severe form, nonalcoholic …
Les valeurs à suivre à Paris et en Europe : ADP, Eramet, Korian ...
07:30am, Monday, 22'nd Jun 2020
PARIS (Reuters) - Les valeurs à suivre lundi à la Bourse de Paris et en Europe où les contrats à terme signalent une ouverture en nette baisse:
* ADP - Le gestionnaire des aéroports parisiens AD
Bourse de Paris : Les valeurs à suivre à Paris et en Europe
07:05am, Monday, 22'nd Jun 2020BOURSE-Les valeurs à suivre à Paris et en Europe (actualisé)
06:55am, Monday, 22'nd Jun 2020
(Actualisé avec automobile/Chine, Wirecard, Korian)
* Variation des futures sur indice CAC 40 0#FCE:
* Variation des futures sur indice Stoxx 600 0#FXXP:
* Valeurs qui se traitent ex-divi
Europe : Les valeurs à suivre à Paris et en Europe
06:21am, Monday, 22'nd Jun 2020
PARIS (Reuters) - Les valeurs à suivre lundi à la Bourse de Paris et en Europe où les contrats à terme signalent une ouverture en nette baisse:* ADP - Le …
